What must be considered when prescribing hormonal pharmacotherapy for male infertility?

Expert Opin Pharmacother. 2022 Jun;23(9):1003-1008. doi: 10.1080/14656566.2022.2043272. Epub 2022 Feb 28.

Authors

Olivia Holtermann Entwistle¹, Aditi Sharma¹, Channa N Jayasena¹

Affiliation

¹ Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.

PMID: 35220845
DOI: 10.1080/14656566.2022.2043272

No abstract available

Keywords: Male infertility; aromatase inhibitors; gonadotropins; hormonal therapy; selective estrogen receptor modulators.

Publication types

Editorial

MeSH terms

Antineoplastic Agents, Hormonal / therapeutic use
Aromatase Inhibitors / therapeutic use
Breast Neoplasms* / drug therapy
Humans
Infertility, Male* / drug therapy
Male
Selective Estrogen Receptor Modulators / therapeutic use

Substances

Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Selective Estrogen Receptor Modulators